Meyers M O, Heinrich S, Kline R, Levine E A
Section of Surgical Oncology, Louisiana State University Medical Center, New Orleans, USA.
Am Surg. 1998 Nov;64(11):1074-6.
The care of patients refusing blood transfusion who require major ablative surgery for malignancy is a continuing challenge. The use of recombinant human erythropoietin is clearly efficacious in patients with renal disease and may be useful in anemic patients who refuse transfusion. Herein, we report a successful extended hemipelvectomy in a Jehovah's Witness using recombinant human erythropoietin support.
对于那些因恶性肿瘤需要进行大面积切除手术但拒绝输血的患者的护理是一项持续的挑战。重组人促红细胞生成素的使用在肾病患者中显然是有效的,并且可能对拒绝输血的贫血患者有用。在此,我们报告了一例在重组人促红细胞生成素支持下,为一名耶和华见证会信徒成功实施扩大半骨盆切除术的病例。